Please login to the form below

Not currently logged in
Email:
Password:

The Creative Engagement Group launches Axiom

Will have offices based in London, Plymouth and Manchester, UK

The Creative Engagement Group (TCEG) has announced it will soon launch its medical training and scientific engagement division, Axiom, in Europe.

TCEG

L-R: Mike Ballas, Russ Lidstone and Jayne Marks

The new division combines the healthcare communications team in the UK, formerly part of WRG, with the US Axiom team.

This will allow TCEG to offer a wider range of scientific and creative engagement services to its clients, the company confirms, and says that Axiom now has an “even greater capability to combine its medical training and engagement expertise, with the creative, live events, environments, film and immersive technology services of the broader group”.

Led globally by Mike Ballas, the Axiom Europe team will be headed by Jayne Marks, and will oversee its presence in London, Plymouth, Manchester in the UK.

The offices will add to the group’s already established base in Yardley and Philadelphia in the US.

Mike Ballas, Global CEO of Axiom said:  “This is a truly exciting opportunity to grow Axiom’s offerings on a global scale. By combining our US training and strategy expertise with the scientific engagement capabilities in the UK, we’ll be able to deliver a unique, best-in-class value proposition to our clients.

The enhanced Axiom team will blend their knowledge, industry experience and creativity with the outstanding capabilities of The Creative Engagement Group to partner with our clients to deliver unforgettable experiences that drive scientific engagement and business performance”.

Axiom will work with cross-functional pharmaceutical and biotech teams, and claims its leadership team are all veterans of the pharmaceutical industry.

Russ Lidstone, Group CEO of The Creative Engagement Group, said: “We are delighted to launch Axiom in Europe. This launch comes at a time when clients are increasingly looking to us to provide strategic leadership and engaging, innovative content that can be executed using a range of channels including live events and immersive technologies.

“This move really strengthens The Creative Engagement Group’s offering and reaffirms our strategic capability in healthcare, both in Europe and the US”.

TCEG is a division of Huntsworth, which acquired the group back in 2017.

2nd May 2019

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....